If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Annalisa Mondi is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 21 Similar Profiles
HIV-1 Medicine & Life Sciences
HIV Medicine & Life Sciences
Ritonavir Medicine & Life Sciences
Lamivudine Medicine & Life Sciences
Italy Medicine & Life Sciences
Maintenance Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Viral Load Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2017 2019

  • 122 Citations
  • 4 h-Index
  • 11 Article

Characterisation of HIV-1 molecular transmission clusters among newly diagnosed individuals infected with non-B subtypes in Italy

Fabeni, L., Alteri, C., Berno, G., Scutari, R., Orchi, N., De Carli, G., Bertoli, A., Carioti, L., Gori, C., Forbici, F., Salpini, R., Vergori, A., Gagliardini, R., Cicalini, S., Mondi, A., Pinnetti, C., Mazzuti, L., Turriziani, O., Colafigli, M., Borghi, V. & 10 others, Montella, F., Pennica, A., Lichtner, M., Girardi, E., Andreoni, M., Mussini, C., Antinori, A., Ceccherini-Silberstein, F., Perno, C. F. & Santoro, M. M., Jan 1 2019, In : Sexually Transmitted Infections. p. 1-7 7 p.

Research output: Contribution to journalArticle

Italy
HIV-1
CD4 Lymphocyte Count
Logistic Models
Viral Load
2 Citations (Scopus)

Effectiveness of dolutegravir-based regimens as either first-line or switch antiretroviral therapy: data from the Icona cohort

ICONA Foundation Study group, Jan 1 2019, In : Journal of the International AIDS Society. 22, 1, p. 1-10 10 p., e25227.

Research output: Contribution to journalArticle

Therapeutics
Tenofovir
dolutegravir
Group Psychotherapy
Proportional Hazards Models
Virus Diseases
HIV
T-Lymphocytes
Infection
T-Lymphocyte Subsets

Italian expert panel consensus statements on two-drug antiretroviral regimens to treat naïve and virologically suppressed HIV-1 infected patients

Two-Drug Antiretroviral Regimens expert panel, Apr 1 2019, In : The new microbiologica. 42, 2, p. 69-80 12 p.

Research output: Contribution to journalArticle

HIV-1
HIV
Pharmaceutical Preparations
Guidelines
Costs and Cost Analysis
Open Access
Art
T-Lymphocytes
HIV Infections
Myeloid-Derived Suppressor Cells
Granulocyte-Macrophage Colony-Stimulating Factor